Totus Medicines
Latest round
- Series B
Last raised
- Dec 2022
Total raised
- $108M
Investors
- 5
About Totus Medicines
Founded in 2019 and headquartered in Emeryville, California, Totus Medicines Inc. focuses on therapeutic solutions for complex diseases.Totus Medicines specializes in the development of innovative therapeutic solutions aimed at addressing previously untreatable diseases. Their core offerings include a proprietary high-throughput drug discovery platform that enables the identification of drug candidates at an unprecedented scale and speed. This platform leverages covalent molecules as a universal key to unlock 'undruggable' targets, significantly enhancing the potential to create effective treatments for complex conditions such as advanced forms of cancer, heart disease, and neurodegeneration. The company focuses on utilizing genomic data to design life-changing medicines, with particular emphasis on targeting the most mutated oncogenes in oncology.The revenue generation model for Totus Medicines is centered around partnerships and collaborations with pharmaceutical entities and research organizations. The company engages in B2B transactions, supplying its drug discovery services and technologies to its clients. These partnerships may include fee-for-service agreements, milestone payments, and revenue-sharing arrangements based on the success of developed therapeutics. Totus Medicines is known for its flagship products tailored for oncology, which may involve subscription-based access to their drug discovery platform or milestone payments resulting from successful drug development outcomes.In December 2023, Totus Medicines Inc. The company aims to develop new products for the treatment of complex diseases and plans to enhance its market presence in North America and select European markets by 2024.
Who invested in Totus Medicines
5 investors across 3 rounds
See all investors in Totus Medicines
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Totus Medicines
Who invested in Totus Medicines?
Totus Medicines has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Totus Medicines raised?
Totus Medicines has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Totus Medicines last raise money?
Totus Medicines's most recent round on record is a Series B, in Dec 2022.
What does Totus Medicines do?
Founded in 2019 and headquartered in Emeryville, California, Totus Medicines Inc.
Where is Totus Medicines headquartered?
Totus Medicines is headquartered in Emeryville, US.
Which VCs invest in companies like Totus Medicines?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Totus Medicines's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Totus Medicines? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.